Profound Medical prices $36M registered direct offering and up to $4M private placement at $7.00/share

Profound Medical Corp.

Sold 5,142,870 common shares at $7.00 each in registered direct offering; gross proceeds ~$36M.
Planned private placement in Canada of up to 571,428 common shares at $7.00 for up to $4M additional proceeds.
Both tranches have no warrant coverage; placement agent is Konik Capital Partners (5% cash fee).
Registered direct closing expected Dec 22, 2025; private placement closing on or before Dec 30, 2025.
Net proceeds for sales/marketing expansion, working capital, R&D, and strategic transactions.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.